版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
CellDifferentiation&Cancer腫瘤學(xué)細(xì)胞分化細(xì)胞分化(differentiation)是指同源細(xì)胞逐漸發(fā)育成具備穩(wěn)定形態(tài)結(jié)構(gòu)、生理功能和生化特征的另一類型細(xì)胞的過(guò)程。細(xì)胞分化過(guò)程是由一系列基因產(chǎn)物(regulatoryproteins)調(diào)控的。
i.e.,每個(gè)基因的表達(dá)都必須:在正確的細(xì)胞中;在正確的時(shí)間;對(duì)正確的信號(hào)產(chǎn)生正確的反應(yīng);產(chǎn)生正確的表達(dá)水平。腫瘤學(xué)細(xì)胞分化例子:眼形成的關(guān)鍵調(diào)控蛋白Ey(果蠅)ey
基因早期細(xì)胞(發(fā)育成腿)腿中眼細(xì)胞分化眼形成腫瘤學(xué)細(xì)胞分化InductionofPluripotentStemCellsfromAdultHumanFibroblastsbyDefinedFactorsCell2007,131,861-872(Oct3/4,Sox2,Klf4,c-Myc
)腫瘤學(xué)細(xì)胞分化腫瘤學(xué)細(xì)胞分化LeukemiaAcuteChronicLymphoidMyeloidLymphoidMyeloid(CLL)(CML)(ALL)AMLM0M1M2M3M4M5M6M7FAB:腫瘤學(xué)細(xì)胞分化
M2t(8;21)AML1-ETOM1t(9;22)M5t(9;11)M3t(15;17)PML-RARαacutepromyelocyticleukemia“Acutemyelogenousleukemias(AMLs)aregeneticallyheterogeneousandcharacterizedbychromosomalrearrangementsthatproducefusionproteinswithaberranttranscriptionalregulatoryactivities.”MyriamAlcalayet.al.,2003FAB,TranslocationandFusionProteins腫瘤學(xué)細(xì)胞分化M3t(15;17)PML-RARαacutepromyelocyticleukemia“Acutepromyelocyticleukemia(AMLM3)isnowthemostfrequentlycurableacuteleukaemiainadultsifpromptlydiagnosedandadequatelytreated.”ParmarS,TallmanMS.,2003腫瘤學(xué)細(xì)胞分化DifferentiationTherapyDifferentiationtherapiesarebroadlydefinedasthosethatinducemalignantreversion(i.e.themalignantphenotypebecomesbenign).Clinically,thesetherapieshavebeenmostsuccessfulforacutepromyelocyticleukemia(APL),withtheuseofall-transretinoicacid(ATRA).Thistreatmenthaschangedacancerwithapreviouslydismaloutcomeintooneofthemosttreatableformsofleukemia.Theexactmechanismsofdifferentiationareunknown—itisunclearifitoccursbyinducingterminaldifferentiation(G0arrest),byinducingdifferentiation‘backwards’tothenon-malignantformofthecell,orbytriggeringapoptosis.ItislikelythatitinvolvesallofthesepathwaysAlexanderISpiraet.Al.,Differentiationtherapy,CurrentOpinioninPharmacology2003腫瘤學(xué)細(xì)胞分化1949:describedinFranceasaleukemiawithexaggeratedhemorrhagicsymptoms1957Hillestadcoinsitpromyelocyticleukemia1977t(15;17)describedinthreeptsRowleyetalLancet.DrugGeneATRAandacutepromyelocyticleukemia
(APL)腫瘤學(xué)細(xì)胞分化1988:Breakthroughintreatment
fromChina腫瘤學(xué)細(xì)胞分化1990:MultiplegroupsidentifyRARaast(15;17)breakpoint腫瘤學(xué)細(xì)胞分化AcutePromyelocyticLeukemiaSTAT5b(17q21)Blood93,3167(1999)腫瘤學(xué)細(xì)胞分化Howdoyoutestifafusionproteinisoncogenic?+PNAS96,15103(1999)腫瘤學(xué)細(xì)胞分化HowdoesPML-RARainducesAPL?
HowdoesATRAinduceremission?腫瘤學(xué)細(xì)胞分化LossofactivationdomainCoiled-coildomainallowsdimerization腫瘤學(xué)細(xì)胞分化CorepressorCoactivatorRARRXR腫瘤學(xué)細(xì)胞分化Jepsen,K.etal.JCellSci2002;115:689-698Transcriptionalrepressionbynuclearreceptorsisregulatedbyrecruitmentoftheco-repressorsN-CoRand/orSMRT腫瘤學(xué)細(xì)胞分化Atsumi,Aetal
BBRC(2006)345:1475HDAC3RecruitmentAbolishedbyATRAGraphicfromMillipore腫瘤學(xué)細(xì)胞分化ATRAresolvesthedifferentiationblockint(15;17)acutemyeloidleukemiabyrestoringPU.1expression腫瘤學(xué)細(xì)胞分化Figure1.ConditionalexpressionofPML-RARAinmyeloidcellssuppressesPU.1.Figure2.LeukemiccellsfromapatientwithAPL(HT93cells)havesuppressedPU.1expression.腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure3.ATRArestoresPU.1expressioninAPLcells腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure4.CEBPfactorsandOCT-1induceactivityoftheproximalPU.1promoterinHT93AAPLcellsfollowingATRAstimulation腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure5.PU.1expressioninprimaryAPLcells:inversecorrelationwithPML-RARAatdiagnosis,andinductionofexpressionfollowingtreatmentwithATRAinvivo腫瘤學(xué)細(xì)胞分化Copyright?2006AmericanSocietyofHematology.Copyrightrestrictionsmayapply.Mueller,B.U.etal.Blood2006;107:3330-3338Figure6.RestoringPU.1expressioninPML-RARAleukemiccellsinducesgranulocyticdifferentiation腫瘤學(xué)細(xì)胞分化Mueller,B.U.etal.Blood2006;107:3330-3338Figure7.ReductionofPU.1expressionbysiRNAblocksATRA-induceddifferentiationofHT93AcellsPU.1expression腫瘤學(xué)細(xì)胞分化hCG-PML-RARaPU.1+/-F1cross(informativeprogeny)Wild-typePU.1+/-hCG-PML-RARahCG-PML-RARa XPU.1+/-DoeslossofonecopyofPU.1contributetoPML-RARadrivenAPL?
LowpenetranceofAPL?腫瘤學(xué)細(xì)胞分化YES:PU.1+/-miceexpressing
PML-RARahaveahighpenetranceofAPLPNAS102,12513(2005)腫瘤學(xué)細(xì)胞分化PU.1mutations
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度山地承包與森林資源評(píng)估合同4篇
- 2025年度房地產(chǎn)企業(yè)內(nèi)部控制制度建立與執(zhí)行合同4篇
- 縱火行為的預(yù)防與打擊
- 2025年度模特與時(shí)尚品牌合作限量版合同4篇
- 2025年度民房買賣交易保障服務(wù)合同4篇
- 2025年度摩托車配件定制加工合同模板2篇
- 2025年度城市軌道交通農(nóng)民工勞動(dòng)合同樣本2篇
- 二零二五年度內(nèi)衣銷售代理區(qū)域保護(hù)合同規(guī)范
- 2025年度美容院健康體檢與會(huì)員服務(wù)合同2篇
- 2025年度新能源車輛運(yùn)輸合同
- TB 10012-2019 鐵路工程地質(zhì)勘察規(guī)范
- 新蘇教版三年級(jí)下冊(cè)科學(xué)全冊(cè)知識(shí)點(diǎn)(背誦用)
- 鄉(xiāng)鎮(zhèn)風(fēng)控維穩(wěn)應(yīng)急預(yù)案演練
- 腦梗死合并癲癇病人的護(hù)理查房
- 蘇教版四年級(jí)上冊(cè)脫式計(jì)算300題及答案
- 犯罪現(xiàn)場(chǎng)保護(hù)培訓(xùn)課件
- 扣款通知單 采購(gòu)部
- 電除顫操作流程圖
- 湖北教育出版社三年級(jí)下冊(cè)信息技術(shù)教案
- 設(shè)計(jì)基礎(chǔ)全套教學(xué)課件
- IATF16949包裝方案評(píng)審表
評(píng)論
0/150
提交評(píng)論